Clinical Trial Update: A 12-weeks Study to Evaluate Sulforaphane in the Treatment of Depression [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating sulforaphane for depressive disorder; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder

Drugs mentioned

• Sulforaphane (sulforaphane)

Snippet

Sponsor: Central South University | Conditions: Depressive Disorder | Phase 2 | Status: UNKNOWN